Patents
Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619)
07/2009
07/22/2009CN101486684A Preparation of 2,4-dichloro-5-methoxy pyrimidine
07/22/2009CN100516052C Alcohol amide condensed ester compound and its preparation and use
07/21/2009US7563922 catalytic chemical preparation of intermediate 4-(2-cyanoethenyl)-2,6-dimethylbenzenamine stereoisomers in presence of palladium chloride; having HIV inhibiting properties
07/21/2009US7563909 Nitrate derivatives of atorvastatin with improved pharmacological activity and enhanced tolerability; coronary syndromes, neurodegenerative disorders, and for reducing cholesterol levels; antiinflammatory, antithrombotic and antiplatelet activity; fluvastatin 4-(nitrooxy)butyl ester
07/21/2009US7563894 e.g. [2-(4-Isopropyl-piperazin-1-yl)-benzooxazol-6-yl]-[5-(4-methoxy-phenyl)-pyrimidin-2-yl]-amine; C-kit kinase receptor or stem cell factor inhibitors; anticarcinogenic agents; veterinary medicine
07/21/2009US7563781 Such as 1-dimethylamino-3-[4-(3-indan-5-yl-3H-[1,2,3]triazolo[4,5-d]pyrimidin-5-ylamino)-phenoxy]-propan-2-ol; serine-tyrosine and tyrosine kinase inhibitors; cancer, metastasis
07/16/2009WO2009089462A1 5h-cyclopenta[d]pyrimidines as akt protein kinase inhibitors
07/16/2009WO2009089459A1 Hydroxylated pyrimidyl cyclopentanes as akt protein kinase inhibitors
07/16/2009WO2009089453A1 Hydroxylated pyrimidyl cyclopentane as akt protein kinase inhibitor
07/16/2009WO2009088729A1 Process for preparing n-substituted hydroxypyrimidinone carboxamides
07/16/2009WO2009062036A3 Processes for preparing levocetirizine and pharmaceutically acceptable salts thereof
07/16/2009US20090181995 2-anilino-4-aminoalkyleneaminopyrimidines
07/16/2009US20090181992 (s)-phenyl(heterocycle)methanol-based compounds, compositions comprising them and methods of their use
07/16/2009US20090181991 Compounds and compositions as protein kinase inhibitors
07/16/2009US20090181983 Six-membered heterocycles useful as serine protease inhibitors
07/16/2009US20090181971 Inhibitors of Histone Deacetylase
07/16/2009CA2711782A1 5h-cyclopenta[d]pyrimidines as akt protein kinase inhibitors
07/16/2009CA2711699A1 Hydroxylated pyrimidyl cyclopentanes as akt protein kinase inhibitors
07/16/2009CA2711692A1 Hydroxylated pyrimidyl cyclopentane as akt protein kinase inhibitor
07/16/2009CA2710987A1 Process for preparing n-substituted hydroxypyrimidinone carboxamides
07/15/2009EP2077999A1 Hydroxamates as inhibitors of histone deacetylase
07/15/2009EP2077841A1 Novel substituted pyrimidines as cysteine protease inhibitors
07/15/2009CN101484429A Heterocyclic aspartyl protease inhibitors
07/15/2009CN101481359A Cyclic protein tyrosine kinase inhibitors
07/15/2009CN101481356A Processes for the preparation of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino]benzonitrile
07/15/2009CN100513386C Amide for inhibition of IL-8-induced chemiotaxis of neutrophil leucocytes
07/15/2009CN100512879C Conjugate having cleavable linkage for use in liposome
07/14/2009US7560589 Cycloalkylidene compounds as modulators of estrogen receptor
07/14/2009US7560566 catalytic carboxylation of 3-methylpyridine to form nicotinic acid in presence of manganese bromide and in an aqueous solvent under supercritical conditions
07/14/2009US7560558 quinoline pyridyl derivatives antagonist; antitumor agents; renal disease, hepatic fibrosis, cirrhosis, fibroid lung, scleroderma, wound healing, arthritis, congestive cardiac disease, ulcer, ocular disorder, cornea disorder, diabetic nephropathy
07/14/2009US7560461 Quinazoline derivatives as kinase inhibitors
07/14/2009US7560458 Triazolopyrimidine derivatives as glycogen synthase kinase 3 inhibitors
07/09/2009WO2009085797A1 Processes for preparing hiv reverse transcriptase inhibitors
07/09/2009WO2009084695A1 2-aminoquinazoline derivative
07/09/2009WO2009084546A1 Compound for organic electroluminescent device and organic electroluminescent device using the same
07/09/2009WO2009083739A1 Method of synthesis of bosentan, its polymorphic forms and its salts
07/09/2009WO2009083608A1 Quinazolines and related heterocyclic compounds, and their therapeutic use
07/09/2009WO2009038752A3 3-substituted 1,2,3-triazin-4-one's and 3-substituted 1,3-pyrimidinone's for enhancing glutamatergic synaptic responses
07/09/2009WO2008154642A3 Antibacterial agents
07/09/2009US20090176983 Tenofovir Disoproxil Hemi-Fumaric Acid Co-Crystal
07/09/2009US20090176981 Stereoisomerically Enriched 3-Aminocarbonyl Bicycloheptene Pyrimidinediamine Compounds And Their Uses
07/09/2009US20090176812 3 -(4-Isopropoxyphenyl)-2-methyl-5-{[2'-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)biphenyl-4-yl]methyl}-6-propylpyrimidin-4(3H) -one; for cardiovascular diseases, metabolic diseases and/or central nervous system diseases
07/09/2009US20090176811 Substituted 5,6,7,8-Tetrahydro-pyrido[4,3-d]pyrimidine-2-yl Compounds and 5,6,7,8-Tetrahydro-quinazoline-2-yl Compounds
07/09/2009US20090176784 Anti-infective agents and uses thereof
07/09/2009US20090176780 Nitrogenous heterocyclic compounds
07/09/2009US20090176774 Compounds and methods of use
07/09/2009US20090176766 Imidazolidinone and imidazolidinethione derivatives
07/09/2009CA2711272A1 Quinazolines and related heterocyclic compounds, and their therapeutic use
07/09/2009CA2711043A1 Method of synthesis of bosentan, its polymorphic forms and its salts
07/08/2009EP2077263A1 Quinazolines and related heterocyclic compounds and their therapeutic use
07/08/2009EP2076498A1 Preparation of azoxystrobin
07/08/2009EP2076491A1 New benzamide derivatives as bradykinin antagonists
07/08/2009EP2076489A1 Arylsulfonamidyl tetralin derivatives and uses thereof
07/08/2009CN101479238A Amine derivative having npyy5 receptor antagonist activity
07/08/2009CN101475537A Preparation of 2,4-dichloroquinazoline
07/08/2009CN101475536A Polysubstituted S-DACO derivative, synthesizing method and use thereof
07/08/2009CN101475535A Polysubstituted N-DACO derivative, synthesizing method and use thereof
07/08/2009CN101475534A Two-photon three-dimensional optical storage material multi-branch pyrimidine derivative and synthesizing method thereof
07/08/2009CN101475526A Carboxylic acid derivatives inhibiting the binding of integrins to receptors thereof
07/08/2009CN100509813C Hetereoaryl nitrile derivative
07/08/2009CN100509801C HIV inhibiting pyrimidines derivatives
07/08/2009CN100509771C Method for the production of sulphamic acid halogenides
07/08/2009CN100509759C Novel alpha-oxygenated or alpha-thiolated carboxylic acid penethylamide derivatives
07/07/2009US7557210 Antiinflamamtory agents
07/07/2009US7557125 Fab I inhibitors
07/07/2009US7557116 Substance which exhibits antiviral and antibacterial activity and is based on derivatives of 2,8-dithioxo-1H-pyrano[2,3d 6,5-d′]dipyrimidyne and 10-aza-analogue thereof
07/07/2009US7557115 Compounds for modulation of kinesins as anticancer agents with administering
07/07/2009US7557106 inhibitors of FLT-3, Aurora-1, Aurora-2, and Aurora-3 protein kinases; leukemia; N-{4-[4-(5-Methyl-2H-pyrazol-3-ylmethyl)-6-(4-propyl-piperazin-1-yl)-pyrim- idin-2-ylsulfanyl]-phenyl}-propionamide
07/07/2009CA2539969C Process for the preparation of carboxylic acids of nitrogen-containing aromatic heterocyclic compounds
07/07/2009CA2438324C Acylated 6,7,8,9-tetrahydro-5h-benzocycloheptenyl amines and their use as pharmaceutical
07/07/2009CA2345353C Null igf for the treatment of cancer
07/02/2009WO2009081892A1 Novel catechol derivative, pharmaceutical composition containing the same, and use of those
07/02/2009WO2009081789A1 Sulfonyl substituted 6-membered ring derivative
07/02/2009WO2009081222A1 Substituted tricyclic pyridine or pyrimidine vanilloid receptor ligands
07/02/2009WO2009080638A2 Sulfamides as zap-70 inhibitors
07/02/2009WO2009080248A1 Substituted 2-phenylpyrimidine-5-carboxylic acids and the use thereof
07/02/2009WO2009080242A1 Substituted 4-aminopyrimidine-5-carboxylic acid and use thereof
07/02/2009WO2009080200A1 Novel sulphoximide-substituted quinoline and quinazoline derivatives as kinase inhibitors
07/02/2009WO2009080199A1 4-(4-cyano-2-thioaryl)dihydropyrimidinones and use thereof
07/02/2009US20090171086 2,4-pyrimidinediamine compounds and their uses
07/02/2009US20090171085 N2,N4-bis(4-ethoxyphenyl)-5-fluoro-2,4-pyrimidinediamine; inhibit the IgE and/or IgG receptor signaling cascades that lead to the release of chemical mediators; Syk kinase inhibitors
07/02/2009US20090171084 Production method of aminopyrimidine compound
07/02/2009US20090171083 Process for producing 4-aminoquinazoline compound
07/02/2009US20090171082 Mitotic kinesin inhibitors
07/02/2009US20090170883 3-arylphenyl sulfide derivative and insecticide and miticide
07/02/2009US20090170881 New inhibitors of histone deacetylase
07/02/2009US20090170877 5,6-Trimethylenepyrimidin-4-one compounds
07/02/2009US20090170836 New inhibitors of histone deacetylase
07/02/2009CA2710298A1 Chemical compounds
07/02/2009CA2710118A1 Sulfamides as zap-70 inhibitors
07/02/2009CA2707447A1 Sulfonyl-substituted 6-membered ring derivative
07/01/2009EP2074104A1 Process for preparing 6-phen0xypyrimidin-4-ol derivatives in the presence of a quinuclidine or a n-methyl pyrrolidine derivative
07/01/2009EP2074103A1 6-phenylpyrimidinones as pim modulators
07/01/2009EP2074083A1 New sulfonamide derivatives as bradykinin antagonists
07/01/2009EP1784393B1 Quinazolines useful as modulators of ion channels
07/01/2009EP1423362B1 New mandelic acid derivative and its use as thrombin inhibitor
07/01/2009EP1226127B1 Substituted phenyl sulfamoyl carboxamides
07/01/2009CN101472900A Therapeutic or prophylactic agent for multiple sclerosis
07/01/2009CN101468965A Biaryl substituted 6-membered heterocyles as sodium channel blockers
07/01/2009CN100506807C Amide derivatives as GK activators